Fiche société
Annovis Bio Inc.
Traitements, essais et publications liés.
Traitements3programmes
Essais2liés
Publications0liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| buntanetap/posiphenThis study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD. | Alzheimer, Parkinson | Phase 2/3 | À vérifier | United States | À vérifier |
| buntanetap/posiphenThis study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD. | Alzheimer | Phase 2/3 | À vérifier | À vérifier | |
| buntanetap/posiphenThis study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD. | Parkinson | Phase 2/3 | À vérifier | United States | À vérifier |
Essais cliniques
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| buntanetap/posiphen | Parkinson | Phase 2/3 | NCT07284784 | A Study of Buntanetap in Participants With PD | RECRUITING |
| buntanetap/posiphen | Alzheimer | Phase 2/3 | NCT07757204 | An Open-label Long-term Safety Study of Buntanetap in Participants With AD | NOT_YET_RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||